chr7-150958110-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_000238.4(KCNH2):ā€‹c.865G>Cā€‹(p.Glu289Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000262 in 1,144,896 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…).

Frequency

Genomes: not found (cov: 33)
Exomes š‘“: 0.0000026 ( 0 hom. )

Consequence

KCNH2
NM_000238.4 missense

Scores

6
8
5

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 1.69
Variant links:
Genes affected
KCNH2 (HGNC:6251): (potassium voltage-gated channel subfamily H member 2) This gene encodes a component of a voltage-activated potassium channel found in cardiac muscle, nerve cells, and microglia. Four copies of this protein interact with one copy of the KCNE2 protein to form a functional potassium channel. Mutations in this gene can cause long QT syndrome type 2 (LQT2). Transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, May 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
KCNH2NM_000238.4 linkuse as main transcriptc.865G>C p.Glu289Gln missense_variant 4/15 ENST00000262186.10 NP_000229.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
KCNH2ENST00000262186.10 linkuse as main transcriptc.865G>C p.Glu289Gln missense_variant 4/151 NM_000238.4 ENSP00000262186 P1Q12809-1
KCNH2ENST00000532957.5 linkuse as main transcriptn.1088G>C non_coding_transcript_exon_variant 4/92
KCNH2ENST00000684241.1 linkuse as main transcriptn.1698G>C non_coding_transcript_exon_variant 2/13

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000262
AC:
3
AN:
1144896
Hom.:
0
Cov.:
31
AF XY:
0.00000365
AC XY:
2
AN XY:
548150
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000313
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Long QT syndrome Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJul 17, 2023In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1764220). This variant has not been reported in the literature in individuals affected with KCNH2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 289 of the KCNH2 protein (p.Glu289Gln). -
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 25, 2023The p.E289Q variant (also known as c.865G>C), located in coding exon 4 of the KCNH2 gene, results from a G to C substitution at nucleotide position 865. The glutamic acid at codon 289 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.32
BayesDel_addAF
Pathogenic
0.27
D
BayesDel_noAF
Pathogenic
0.15
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.51
D;T
Eigen
Uncertain
0.33
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.92
D;D
M_CAP
Pathogenic
0.95
D
MetaRNN
Uncertain
0.51
D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Benign
1.6
L;.
MutationTaster
Benign
0.99
D;D;D
PrimateAI
Pathogenic
0.95
D
PROVEAN
Benign
-1.3
N;.
REVEL
Pathogenic
0.76
Sift
Uncertain
0.0080
D;.
Sift4G
Benign
0.37
T;T
Polyphen
0.97
D;.
Vest4
0.22
MutPred
0.49
Gain of MoRF binding (P = 0.0297);.;
MVP
0.94
MPC
1.8
ClinPred
0.90
D
GERP RS
3.8
Varity_R
0.28
gMVP
0.66

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199472880; hg19: chr7-150655198; API